Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: The effect of ursodeoxycholic acid

British Journal of Haematology

Volumn 96, Issue 4, 1997, Pages 776-780

  Wulffraat, Nico M ^a,c   Haddad, Elie ^b   Benkerrou, Malika ^b   Spliet, Wim G M ^a   Patey, Natacha ^b   Fischer, Alain ^b   De Graeff Meeder, Babette R ^a  

^a Univ Hosp Children Het W   (Netherlands)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

hepatic GVHD; SCID; ursodiol

Indexed keywords

ANTIBODY; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LFA ANTIBODY; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; COMBINED IMMUNODEFICIENCY; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 0031057226     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2085.x     Document Type: Article

References (12)

1. Balan, V., Rolland Dickson, B.S., Jorgensen, R.A. & Lindor, K. (1994) Effects of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. Mayo Clinic Proceedings, 69, 923-929.
2. Dror, Y., Gallagher, R., Wara, D.W., Colombe, B.W., Merino, A., Benkerrou, M. & Cowan, M.J. (1993) Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood. 81, 2021-2030.
3. Fischer, A., Durandy, A., de Villarty, J.P., Vilmer, E., le Deist, E., Gerota, I. & Griscelli, C. (1986) HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine. Blood, 67, 444-449.
4. Fischer, A., Friedrich, W., Fasth, A., Blanche, S., Le-Deist, F., Girault, D., Veber, F., Vossen, J., Lopez, M. & Griscelli, C. (1991) Reduction of graft failure by a monoclonal antibody (anti-LFA-1-CD11a) after HLA non-identical bone marrow transplantation in children with immunodeficiencies, osteopetrosis and Fanconi's anemia. Blood, 77, 249-256.
5. Fried, R.H., Murakami, C.S., Fischer, L.D., Wilson, R.A., Sullivan, K.M. & McDonald, G.B. (1992) Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. Annals of Internal Medicine, 116, 624-629.
6. Lindor, K.D., Dickson, E.R., Baldus, W.P., Jorgensen, R.A., Ludwig, J., Murtaugh, P.A., Harrison, J.M., Wiesner, R.H., Anderson, M.L. & Lange, S.M. (1994) Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology, 106, 1284-1290.
7. O'Reilly, R.J., Keever, C.A., Small, T.N. & Brochstein, J. (1989) The use of HLA-non-identical T-cell depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodeficiency Reviews, 1, 273-309.
8. Shulman, H.M., Sharma, P., Amos, D., Fenster, F. & McDonald, G.B. (1988) A coded histologic study of hepatic graft versus host disease after human bone marrow transplantation. Hepatology, 8, 463-470.
9. Stephan, J.L., Vlekova, V., le Deist, F., Blanche, S., Donadieu, J., de Saint-Basille, G., Durandy, A., Griscelli, C. & Fischer, A. (1993) Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients, Journal of Pediatrics. 123, 564-572.
10. Vogelsang, G.B. & Hess, A.D. (1994) Graft-versus-host disease: new directions for a persistent problem. Blood, 84, 2061-2067.
11. Washington, K., Gossage, D.L. & Gottfried, M.R. (1993) Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome. Pediatric Pathology, 13, 485-504.
12. Yoshikawa, M., Tsujii, T., Matsumara, K., Yamao, J., Matsamura, Y. & Kubo, R. (1992) Immunomodulatory effects of ursodeoxycholic acid on immune responses, Hepatology, 16, 358-364.